SCHEMBL5936635

SCHEMBL5936635

COc1cccc(-c2ccccc2NC(=O)COc2ccc(C(=O)NC(Cc3ccc(OCc4ccccc4)cc3)C(=O)O)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.57
ALDH1A1 P00352 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
KDM4E B2RXH2 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
GPR34 Q9UPC5 9/20 0.56
PTPN1 P18031 1/20 0.56
GPR132 Q9UNW8 3/20 0.55
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
ERAP2 Q6P179 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1122724 0.94 KMT2A (0.56) KMT2AALDH1A1L3MBTL1KDM4ENPSR1
SCHEMBL6030433 0.82 GPR132 (0.65) KMT2AGPR34PTPN1GPR132POLB
SCHEMBL18114395 0.81 GPR132 (0.81) GPR34PTPN1GPR132
SCHEMBL1122641 0.81 PTPN1 (0.77) KMT2AALDH1A1GPR34PTPN1GPR132
SCHEMBL1123312 0.81 GPR34 (0.59) GPR34PTPN1GPR132
SCHEMBL5936629 0.79 PTPN1 (0.58) GPR34PTPN1GPR132GAARAB9A
SCHEMBL1123308 0.79 GPR132 (0.62) GPR34PTPN1GPR132
SCHEMBL1122875 0.79 GPR132 (0.79) GPR34PTPN1GPR132
SCHEMBL27658925 0.79 GPR132 (0.79) GPR34PTPN1GPR132
SCHEMBL1123299 0.78 GPR132 (0.77) GPR34PTPN1GPR132GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG KMT2A 1515/4885ALDH1A1 1004/4885L3MBTL1 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.